Integrated metabolomics and lipidomics study of patients with atopic dermatitis in response to dupilumab

Integrated metabolomics and lipidomics study of patients with atopic dermatitis in response to dupilumab

BackgroundAtopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases. Dupilumab, a monoclonal antibody that targets the interleukin (IL)-4 and IL-13 receptors, has been widely used in AD because of its efficacy. However, metabolic changes occurring in patients with AD in res...

Full description

Bibliographic Details
Main Authors: Lishan Zhang, Xueyi Wen, Yibo Hou, Yongshi Yang, Wei Song, Yueping Zeng, Jinlyu Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
atopic dermatitis
dupilumab
metabolomics
lipidomics
different response
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1002536/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1002536/full

Similar Items